Drug Development Costs about 1 Billion Dollars US per Drug?

This was stated in an article today in the Wall Street Journal by the
CEO of a drug company. I can't imagine where all this money goes. Is
this a bogus statement or has a drug company shown its cost accounting
for drug development? If it is true, there has to be something very
wrong with regulations...

"Dan" <dan@nospam.net> wrote in message
news:6dij2tF2pg2oU1@mid.individual.net...
> This was stated in an article today in the Wall Street Journal by the CEO
> of a drug company. I can't imagine where all this money goes. Is this a
> bogus statement or has a drug company shown its cost accounting for drug
> development? If it is true, there has to be something very wrong with
> regulations...

It's accurate. And the regulations are there to protect you

on 7/9/08 1:34 AM Steph said the following:
>
> "Dan" <dan@nospam.net> wrote in message
> news:6dij2tF2pg2oU1@mid.individual.net...
>> This was stated in an article today in the Wall Street Journal by the
>> CEO of a drug company. I can't imagine where all this money goes. Is
>> this a bogus statement or has a drug company shown its cost accounting
>> for drug development? If it is true, there has to be something very
>> wrong with regulations...
>
> It's accurate. And the regulations are there to protect you

where does this money go?

Dan wrote:

> on 7/9/08 1:34 AM Steph said the following:
> >
> > "Dan" <dan@nospam.net> wrote in message
> > news:6dij2tF2pg2oU1@mid.individual.net...
> >> This was stated in an article today in the Wall Street Journal by the
> >> CEO of a drug company. I can't imagine where all this money goes. Is
> >> this a bogus statement or has a drug company shown its cost accounting
> >> for drug development? If it is true, there has to be something very
> >> wrong with regulations...
> >
> > It's accurate. And the regulations are there to protect you
>
> where does this money go?

See my post " Clinical Trials and Pharmaceuticals" yesterday.
J

on 7/10/08 9:19 PM J no> said the following:
> Dan wrote:
>
>> on 7/9/08 1:34 AM Steph said the following:
>>> "Dan" <dan@nospam.net> wrote in message
>>> news:6dij2tF2pg2oU1@mid.individual.net...
>>>> This was stated in an article today in the Wall Street Journal by the
>>>> CEO of a drug company. I can't imagine where all this money goes. Is
>>>> this a bogus statement or has a drug company shown its cost accounting
>>>> for drug development? If it is true, there has to be something very
>>>> wrong with regulations...
>>> It's accurate. And the regulations are there to protect you
>> where does this money go?
>
> See my post " Clinical Trials and Pharmaceuticals" yesterday.
> J
>

I want to see an accounting of the costs just like other companies do.
Without this I don't believe it costs $1B to do the research and then
clinical trials to market (don't include costs after the drug is approved).

Dan

on 7/12/08 9:42 PM Dan said the following:
> on 7/10/08 9:19 PM J no> said the following:
>> Dan wrote:
>>
>>> on 7/9/08 1:34 AM Steph said the following:
>>>> "Dan" <dan@nospam.net> wrote in message
>>>> news:6dij2tF2pg2oU1@mid.individual.net...
>>>>> This was stated in an article today in the Wall Street Journal by the
>>>>> CEO of a drug company. I can't imagine where all this money goes. Is
>>>>> this a bogus statement or has a drug company shown its cost accounting
>>>>> for drug development? If it is true, there has to be something very
>>>>> wrong with regulations...
>>>> It's accurate. And the regulations are there to protect you
>>> where does this money go?
>>
>> See my post " Clinical Trials and Pharmaceuticals" yesterday.
>> J
>>
>
> I want to see an accounting of the costs just like other companies do.
> Without this I don't believe it costs $1B to do the research and then
> clinical trials to market (don't include costs after the drug is approved).
>
> Dan

http://www.cptech.org/ip/health/econ/howmuch.html

Including opportunity cost in the figures is bull shit. How is that
defined? I assume they tack a 'revenue flow for a drug that is fast
tracked to market and made about $998,000,000 so the real spend on
development is around $2,000,000. Pharma is corrupt just like the US
government.

On Jul 12, 10:51*pm, Dan <d...@nospam.net> wrote:
> on 7/12/08 9:42 PM Dan said the following:
>
> > I want to see an accounting of the costs just like other companies do.
> > Without this I don't believe it costs $1B to do the research and then
> > clinical trials to market (don't include costs after the drug is approved).

* gue ]

Expert: First anti-cancer drug tests successful
By ÈTK / Published 14 July 2008

E-mail

RSS feeds

Bookmark
Prague, July 12 (CTK) - The new Czech anti-cancer medicine GS-9219 has
proved very successful in the treatment of tumours when administered
to dogs during the first tests, Zdenek Havlas, head of the Organic
Chemistry and Biochemistry Institute, told Saturday's issue of the
daily Pravo.

The first results of the tests conducted by the U.S. Gilead Sciences
company, indicate that the active substance GS-9212, developed by
Czech scientist Antonin Holy, will probably mean "a revolution" in the
treatment of patients suffering from lymphatic tissue cancer, Pravo
writes.

If the first clinical trials on humans were successful too, the new
medicine might appear in the market in six to eight years, said
Havlas, heading the institute where Professor Holy works.

He told the paper that the first test results were amazing since the
dogs' tumours were removed within five days since the administration
of a single dose of the substance in infusion.

"The substance, metaphorically speaking, was able to turn fatal cancer
into influenza that is being treated in five days," Havlas said.

The GS-9219 active substance directly affects the cancer-hit cells
while not destroying the healthy tissue, Pravo writes.

Gilead Sciences, that will produce the medicine, is now testing the
product in five top institutes in the United States and in another
five facilities in the Czech Republic.

The development of the new anti-cancer medicine from the substance
discovery to the final product will cost about 800 million dollars, 99
percent of which naturally come from the Gilead Science's budget,
Havlas said.

The medicine is so far not designated for veterinary purposes, he
added.
This story is from the Czech News Agency (ÈTK).
The Prague Daily Monitor and Monitor CE are not responsible for its
content.